Drug intelligence / Profile preview

pelviprost compresse

Development stage
Unknown
Lead developer
Epitech
Modality
Small Molecules
Administration
Oral
01

Overview

Pelviprost Compresse is an oral nutraceutical developed by Epitech Group, formulated with micronized and ultramicronized palmitoylethanolamide (PEA) and polydatin. As an ALIAmide-based product, it functions by modulating the activity of mast cells and other non-neuronal immune cells, such as microglia and astrocytes, to control neuroinflammation and peripheral nerve sensitivity. It is primarily indicated for the management of neuroinflammatory disorders of the pelvic area, including chronic prostatitis, benign prostatic hyperplasia (BPH), lower urinary tract symptoms (LUTS), and chronic pelvic pain. The product is marketed in Italy as a food supplement to promote the restoration of normal physiological reactivity in prostatic tissue.

Brand names
PelviprostPelviprost Compresse
Other names
palmitoylethanolamide + polydatin
02

Targets

GPR55 (G protein-coupled receptor 55)SIRT1 (NAD-dependent protein deacetylase sirtuin-1)PPARA (Peroxisome proliferator-activated receptor alpha)

Beyond the preview

Go deeper on pelviprost compresse.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on pelviprost compresse.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call